Biopreservation Market Report 2026

Biopreservation Market Overview

• Biopreservation market size has reached to $6.69 billion in 2025 • Expected to grow to $12.43 billion in 2030 at a compound annual growth rate (CAGR) of 13.2% • Growth Driver: Personalized Medicine Drives Biopreservation Market Growth • Market Trend: Next-Generation Technologies Drive Biopreservation Innovation • North America was the largest region in 2025.

What Is Covered Under Biopreservation Market?

Biopreservation is defined as the use of microorganisms and their metabolic byproducts to increase food safety and shelf life. It is used to preserve biospecimen for a longer period and shield them from any harm outside their native environment. Biospecimens are samples of materials such as urine, blood, tissue, cells, DNA, and others that are kept in a biorepository for future research or utilized for a lab test. The main types of biopreservation are biopreservation equipment and biopreservation media. Biopreservation equipment includes instruments such as bio-based therapeutics, clinical biomarkers, cells, viruses, diagnostic biochips, and others that preserve biospecimens. It is used for many biospecimen, including human tissue samples, organs, stem cells, and others. It is applied for therapeutic applications, research applications, clinical trials, and other purposes and is used by biobanks, gene banks, hospitals, and others.

What Is The Biopreservation Market Growth Forecast?

The biopreservation market size is expected to see rapid growth in the next few years. It will grow to $12.43 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing demand for regenerative medicine samples, expansion of precision medicine research, rising investments in biorepository infrastructure, growing focus on sample quality assurance, increasing global clinical trial activity. Major trends in the forecast period include increasing adoption of advanced cryopreservation techniques, rising demand for long-term biospecimen storage solutions, growing use of specialized biopreservation media, expansion of centralized biorepository facilities, enhanced focus on sample integrity and traceability.

Global Biopreservation Market Segmentation

1) By Type: Biopreservation Equipment, Biopreservation Media 2) By Biospecimen: Human Tissue Samples, Organs, Stem Cells, Other Biospecimens 3) By Application: Therapeutic Applications, Research Applications, Clinical Trials, Other Applications 4) By End User: Biobanks, Gene Banks, Hospitals, Other End Users Subsegments: 1) By Biopreservation Equipment: Freezers, Liquid Nitrogen Tanks, Refrigerators, Incubators 2) By Biopreservation Media: Cryoprotectants, Growth Media, Supplementary Media

What Is The Driver Of The Biopreservation Market?

Increasing demand for personalized medicine is significantly contributing to the growth of the biopreservation market. Personalized medicine is used to treat patients with diseases specific to them. Personalized medicines are developed with the help of biobanks, which preserve human tissues and cells using biopreservation. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Thus, the increasing demand for personalized medicine is expected to propel the biopreservation industry growth going forward.

Key Players In The Global Biopreservation Market

Major companies operating in the biopreservation market are Thermo Fisher Scientific Inc., BioLife Solutions Inc., VWR International LLC, BioCision LLC, Lifeline Scientific Inc., Biomatrica Inc., Custom Biogenic System Inc., QIAGEN NV, ThermoGenesis Holdings Inc., MVE Biological Solutions LLC, Taylor-Wharton America Inc., X-Therma Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., The Merck Group, Azenta US Inc., Avantor Inc., Bio-Techne Corporation, Worthington Industries Inc., Chart Industries Inc., Cryoport Inc., LabVantage Solutions Inc., Brooks Automation Inc., BioVault Technical Ltd., Biomatik Corporation, Biostorage Technologies Inc., Arctiko A/S, Eppendorf AG, Panasonic Healthcare Co. Ltd., BioSpherix Ltd.

Global Biopreservation Market Trends and Insights

Major companies operating in the biopreservation market are focusing on developing innovative solutions, such as cryopreservation solutions, to meet the rising demand for preserving complex tissues and organs over time. Cryopreservation is the process of safeguarding biological material at extremely low temperatures (−196°C), either very quickly, as in seed storage, or gradually with controlled dehydration, offering advantages over traditional storage methods by maintaining viability and functionality over longer periods. For instance, in April 2024, Pluristyx, Inc., a US-based biotechnology company, launched PluriFreeze Cryopreservation Media, designed to enhance the viability and functionality of human-derived pluripotent stem cells (iPSCs) and other delicate cell types during freezing and thawing. PluriFreeze is composed entirely of synthetic and animal-origin-free (AOF) materials. Its low viscosity facilitates automation and large-scale cell production, while the complementary DMSO-free wash solution, PluriPrep, allows extended processing times, optimizing cell handling and recovery for research and clinical applications.

What Are Latest Mergers And Acquisitions In The Biopreservation Market?

In June 2024, DefiniGEN Ltd., a UK-based biotechnology company partnered with Atelerix Ltd. to revolutionize drug testing efficiency. With this partnership, they aim to enhance the efficiency and sustainability of drug testing by enabling the shipping of functional in vitro liver models without the need for cold chain logistics. Atelerix Ltd. is a UK-based biotechnology company focused on the development and commercialization of innovative cell-based therapies and regenerative medicine solutions.

Regional Outlook

North America was the largest region in the biopreservation market share in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biopreservation Market?

The biopreservation market includes revenues earned by entities by providing freezing services, cryogenic storage system services, thawing equipment, and sample refrigeration services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biopreservation Market Report 2026?

The biopreservation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biopreservation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.